{
  "id": 19366295,
  "title": "Beam’s base editing therapy for sickle cell hits goal in pivotal trial",
  "url": "https://urgent.news/2026/11/10/beams-base-editing-therapy-for-sickle-cell-hits-goal-in-pivotal-trial",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-10T17:06:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/beam-sickle-cell-base-editing-risto-cel-results/874242/"
  },
  "original_language": "en",
  "account": null,
  "summary": "The result represents a scientific milestone and positions Beam to submit a first-of-its-kind FDA application as soon as the end of the year.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "Beam says base-edited sickle cell therapy succeeds in Phase 1/2 study",
        "url": "https://urgent.news/2026/11/10/beam-says-base-edited-sickle-cell-therapy-succeeds-in-phase-1-2-study",
        "published": "2026-11-10T16:23:21.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}